LCID
Lucid Group, Inc.
LCID has a slight edge over SABR overall, supported by stronger fundamentals and lower modeled downside.
SABR
Sabre Corporation
SABR offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
SABR Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Under pressure | |
| Weak |
SABR's revenue is currently stable, but its profitability, cash flow and balance sheet are under pressure.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
SABR PE Valuation
SABR has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 20x next year's earnings.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
SABR Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Strongly weakening | |
| Limited | |
| Moderate |
Analysts expect SABR to return to profit, with revenue growing.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
SABR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.09 | — |
| Q3 2026 | -$0.21 | -117% |
| Q2 2026 | $1.83 | +$2.75 |
| Q1 2026 | $1.27 | +$1.72 |
| Q4 2025 | $1.34 | +$2.07 |
| Q3 2025 | $1.22 | +$1.99 |
| Q2 2025 | -$0.92 | +$0.30 |
| Q1 2025 | -$0.45 | +$0.98 |
| Q4 2024 | -$0.73 | +$0.83 |
SABR has the edge over LCID on earnings, with more consistent year-over-year improvement.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over SABR on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
SABR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $738.4M | +3.2% |
| Q2 2026 | $712M | +3.6% |
| Q1 2026 | $760.3M | -2.1% |
| Q4 2025 | $666.5M | -6.7% |
| Q3 2025 | $715.2M | -6.5% |
| Q2 2025 | $687.1M | -10% |
| Q1 2025 | $776.6M | -0.8% |
| Q4 2024 | $714.7M | +4% |
SABR's revenue fell from its 2019 peak and has held roughly level since: $738M last quarter, up 3.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 15% | +1.7 points |
| Q2 2026 | 13% | +0.1 points |
| Q1 2026 | 15% | +1.9 points |
| Q4 2025 | 3.2% | -4.8 points |
| Q3 2025 | 13% | +3.9 points |
| Q2 2025 | 13% | +5 points |
| Q1 2025 | 13% | +0.8 points |
| Q4 2024 | 8% | +2.6 points |
SABR has the edge over LCID on profitability, with a higher operating margin.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
SABR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$47.5M | -454% |
| Q2 2026 | $9.7M | +$232.2M |
| Q1 2026 | -$155.4M | -$56.9M |
| Q4 2025 | $115.8M | +74% |
| Q3 2025 | $13.4M | +78% |
| Q2 2025 | -$222.5M | -2877% |
| Q1 2025 | -$98.5M | -$2.7M |
| Q4 2024 | $66.6M | -14% |
SABR has the edge over LCID on cash flow, with more consistent year-over-year improvement.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
SABR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.1% | +4.3M shares |
| 1 year | -6% | -25.6M shares |
| 3 years | +17% | +58.5M shares |
| 5 years | +25% | +80.9M shares |
| Available history | +46% | +127M shares |
SABR has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
| Q4 2019 | — |
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
SABR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 8.4x | High |
| Q2 2026 | 8.4x | High |
| Q1 2026 | 8.6x | High |
| Q4 2025 | 8.6x | High |
| Q3 2025 | 7.9x | High |
| Q2 2025 | 10.6x | High |
| Q1 2025 | 10.7x | High |
| Q4 2024 | 10.4x | High |
SABR's net debt is about 8.4 years of its operating earnings (EBITDA), up from 7.9 years a year ago.
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
SABR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.2 | Neutral |
| Stochastic | 26.2 | Neutral |
SABR's weekly RSI is 51 (neutral) and its Stochastic is 26 (neutral).
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
SABR PE vs Consumer Cyclical Sector
| Metric | SABR | Sector median | Relative |
|---|---|---|---|
| PE | 0.9x | 18x | 95% below |
| PE % | 5 | 47 | 42 pts below |
SABR has no meaningful PE right now: it lost money over the past year.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
SABR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.81 | 5% above |
| 20 week MA | $1.94 | 2.1% below |
| 50 week MA | $1.69 | 12% above |
| 100 week MA | $2.18 | 13% below |
| 200 week MA | $2.98 | 36% below |
SABR has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.
SABR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $22.9 | $11.4 | -50% |
| 2021 | $11.4 | $8.91 | -22% |
| 2022 | $8.91 | $5.94 | -33% |
| 2023 | $5.94 | $4.40 | -26% |
| 2024 | $4.40 | $3.67 | -17% |
| 2025 | $3.67 | $1.39 | -62% |
| 2026 YTD | $1.39 | $1.90 | +37% |
SABR has the edge over LCID on returns for 2026, with the stronger performance.